 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- |||||||||| Zerun HPV-9 / Walvax
New P3 trial: Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 (clinicaltrials.gov) - Oct 14, 2022
P3, N=1200, Active, not recruiting, Sponsor: Shanghai Zerun Biotechnology Co.,Ltd